Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Fuso Pharmaceutical Industries's share price is 円2194.00.
Fuso Pharmaceutical Industries's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円7,297.18. Hence, Fuso Pharmaceutical Industries's PS Ratio for today is 0.30.
Good Sign:
Fuso Pharmaceutical Industries Ltd stock PS Ratio (=0.3) is close to 10-year low of 0.27.
The historical rank and industry rank for Fuso Pharmaceutical Industries's PS Ratio or its related term are showing as below:
TSE:4538'
s PS Ratio Range Over the Past 10 Years
Min: 0.27 Med: 0.4 Max: 0.58
Current: 0.3
During the past 13 years, Fuso Pharmaceutical Industries's highest PS Ratio was 0.58. The lowest was 0.27. And the median was 0.40.
TSE:4538's PS Ratio is ranked better than 93.71% of 954
companies
in the Drug Manufacturers industry
Industry Median: 2.325
vs TSE:4538: 0.30
During the past 13 years, Fuso Pharmaceutical Industries's highest 3-Year average Revenue per Share Growth Rate was 7.90% per year. The lowest was -1.90% per year. And the median was 2.00% per year.
Back to Basics: PS Ratio
Fuso Pharmaceutical Industries (TSE:4538) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Fuso Pharmaceutical Industries PS Ratio Related Terms
Fuso Pharmaceutical Industries PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Fuso Pharmaceutical Industries's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fuso Pharmaceutical Industries PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Fuso Pharmaceutical Industries's PS Ratio distribution charts can be found below:
* The bar in red indicates where Fuso Pharmaceutical Industries's PS Ratio falls into.
Fuso Pharmaceutical Industries PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Fuso Pharmaceutical Industries's Share Price of today is 円2194.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fuso Pharmaceutical Industries's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円7,297.18.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Fuso Pharmaceutical Industries (TSE:4538) has a PS Ratio of 0.30 as of Jul. 17, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Fuso Pharmaceutical Industries and its competitors. This is 25% below median its historical median of 0.40. Over the past decade, Fuso Pharmaceutical Industries' PS Ratio has ranged from 0.27 to 0.58. According to the industry distribution chart, Fuso Pharmaceutical Industries ranks #60 out of 954 companies in the Drug Manufacturers industry, placing it in the top 6.3%.
Is Fuso Pharmaceutical Industries' PS Ratio too high?
Fuso Pharmaceutical Industries' current PS Ratio of 0.30 is 25% below median its 10-year median of 0.40. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 0.58. The Drug Manufacturers industry median PS Ratio is 2.33. Fuso Pharmaceutical Industries' value of 0.30 is 87.1% below this industry median. Based on the distribution chart, Fuso Pharmaceutical Industries ranks #60 out of 954 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Fuso Pharmaceutical Industries has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fuso Pharmaceutical Industries' PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Fuso Pharmaceutical Industries ranks #60 out of 954 companies for PS Ratio. This places Fuso Pharmaceutical Industries in the top 6% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.33. Fuso Pharmaceutical Industries' value of 0.30 is 87.1% below this benchmark. Historically, Fuso Pharmaceutical Industries' own PS Ratio has ranged from 0.27 to 0.58 over the past decade. While the company's 10-year median is 0.40 vs. the industry median of 2.33, Fuso Pharmaceutical Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.33, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fuso Pharmaceutical Industries's current PS Ratio of 0.30 is 87.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Fuso Pharmaceutical Industries and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fuso Pharmaceutical Industries's current PS Ratio is 0.30, which is 25% below median its own 10-year median of 0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuso Pharmaceutical Industries stock overvalued right now?
Based on GuruFocus' analysis, Fuso Pharmaceutical Industries (TSE:4538) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,556.06, compared to a current price of 円2,194.00 — trading 14.2% below its estimated fair value. The current PS Ratio is 0.30, which is 25% below median its 10-year median of 0.40 and 87.1% below the Drug Manufacturers industry median of 2.33. Fuso Pharmaceutical Industries' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Fuso Pharmaceutical Industries (TSE:4538), the current PS Ratio is 0.30 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fuso Pharmaceutical Industries (TSE:4538) Overvalued in 2026?
Based on GuruFocus' analysis, Fuso Pharmaceutical Industries stock appears to be undervalued.
The current stock price of 円2,194.00 is trading 14.2% below its estimated GF Value™ of 円2,556.06.
GuruFocus considers Fuso Pharmaceutical Industries to be Modestly Undervalued.
Key valuation signals for TSE:4538:
PS Ratio: 0.30 (25% below median its 10-year median of 0.40)
GF Value™: 円2,556.06 vs. price of 円2,194.00 (14.2% below fair value)
Industry Position: 87.1% below the Drug Manufacturers median (#60 of 954)
No single metric tells the full story. See the TSE:4538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fuso Pharmaceutical Industries Business Description
Fuso Pharmaceutical Industries Ltd. is engaged in the manufacture and sale of pharmaceuticals and medical equipment. The company's main products are transfusion fluid and artificial kidney dialysis fluid. Company also includes real estate segment.
51GF Score
Get the complete analysis for TSE:4538
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4538 has been successfully added to your 
